| BCL2L11 — BCL2 Like 11 (BIM) | |
|---|---|
| Symbol | BCL2L11 |
| Full Name | BCL2 Like 11 (BIM) |
| Chromosome | 2q13 |
| NCBI Gene | 10018 |
| Ensembl | ENSG00000113194 |
| OMIM | 603677 |
| UniProt | O43521 |
| Diseases | Parkinson's Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis |
| Expression | Ubiquitous; high expression in neuronal tissues |
BCL2L11 (commonly known as BIM) is a potent pro-apoptotic BH3-only protein that belongs to the Bcl-2 family. It is a key regulator of apoptosis and plays critical roles in neuronal survival and death pathways[1]. BIM has been strongly implicated in neurodegenerative diseases where excessive apoptosis contributes to neuronal loss.
BIM is encoded by the BCL2L11 gene and is alternatively spliced to produce multiple isoforms (BIM-EL, BIM-L, BIM-S) with varying pro-apoptotic activities. The longest isoform, BIM-EL, is the most abundant and potent[2].
The protein contains a BH3 domain that is essential for its pro-apoptotic function. BIM can directly activate pro-apoptotic Bax/Bak proteins or neutralize anti-apoptotic Bcl-2 proteins through BH3 binding. Unlike p53-regulated PUMA, BIM is primarily regulated at the post-translational level—it's kept in check by sequestration to the microtubule cytoskeleton through binding to dynein light chain.
BIM is a critical mediator of apoptosis induced by various cellular stresses including growth factor withdrawal, ER stress, and mitochondrial dysfunction—all processes relevant to neurodegeneration.
In PD:
In AD:
In ALS:
The study of Bcl2L11 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.